AstraZeneca has agreed to acquire Belgian in vivo cell therapy biotech EsoBiotec, strengthening its position in the emerging field of treatments that can reprogramme immune cells inside patients' ...
Massachusetts Institute of Technology and Massachusetts General Hospital researchers have developed a messenger RNA vaccine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results